Literature DB >> 9390637

Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects.

M M Faas1, G A Schuiling, J F Baller, N Valkhof, W W Bakker.   

Abstract

In the present study, we evaluated the effect of low-dose aspirin (acetylsalicylic acid (ASA); 1.0 mg/kg daily) on blood pressure, albumin excretion, glomerular fibrinogen deposits, and glomerular (basement) membrane-bound adenosine diphosphatase (ecto-ADPase) activity, as well as on glomerular inflammation in pregnant rats infused with low-dose endotoxin (1.0 mg/kg). Rats (day 14 of pregnancy) were infused with endotoxin (ET rats) or saline (control rats) and received ASA in their drinking water. These rats were compared with non-ASA-treated rats. Blood pressure and albumin excretion were measured from day 15 to day 21, and glomerular fibrinogen and ecto-ADPase activity were measured at day 21. Glomerular inflammation was evaluated at various times after the start of the infusion. The results show that treatment with ASA had a significant beneficial effect on hypertension and inflammation induced by endotoxin in pregnant rats, whereas it reduced albumin excretion and glomerular fibrinogen deposits in some of the rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390637     DOI: 10.1016/s0022-2143(97)90126-8

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  2 in total

1.  Effects of lipopolysaccharides from gram-negative bacteria on the level of thiols in blood platelets.

Authors:  Joanna Saluk-Juszczak; Barbara Wachowicz; Edward Bald; Rafał Gowacki
Journal:  Curr Microbiol       Date:  2005-07-27       Impact factor: 2.188

2.  Endothelium-dependent relaxation and angiotensin II sensitivity in experimental preeclampsia.

Authors:  Anne Marijn van der Graaf; Marjon J Wiegman; Torsten Plösch; Gerda G Zeeman; Azuwerus van Buiten; Robert H Henning; Hendrik Buikema; Marijke M Faas
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.